| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 89521262IH |
| InChI Key | VAPNKLKDKUDFHK-UHFFFAOYSA-H |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C51H34N6Na6O23S6 |
| Molecular Weight | 1429.19 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Cysteine protease
Cysteine protease CA clan
Cysteine protease C1A family
|
- | - | - | - | 32 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class III
|
- | 1200-1200 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Leukotriene receptor
|
- | - | - | - | 33 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Purine receptor
|
- | - | - | - | 15 | |
|
Transcription factor
|
- | 10400 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Acute Kidney Injury | 2 | D058186 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Adrenal Cortex Neoplasms | 2 | D000306 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Child Development Disorders, Pervasive | 1 | D002659 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Hand, Foot and Mouth Disease | 1 | D006232 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 9364 |
| ChEMBL | CHEMBL413376 |
| EPA CompTox | DTXSID30156024 |
| FDA SRS | 89521262IH |
| SureChEMBL | SCHEMBL414636 |